Rs 72 lakh/year rare-disease drug can be made for Rs 3,000/year, HC told | India News – Times of India
A drug to treat Spinal Muscular Atrophy (SMA) that costs about Rs 72 lakh per patient per year because of patent protection and absence of local production could be produced for as little as Rs 3,000 per year if India would allow local manufacture. This opinion from a drug costing expert was part of an…